Skip to main content
Erschienen in: Journal of Genetic Counseling 3/2016

05.11.2015 | Original Research

Survey of the Definition of Fetal Viability and the Availability, Indications, and Decision Making Processes for Post-Viability Termination of Pregnancy for Fetal Abnormalities and Health Conditions in Canada

verfasst von: Danna Hull, Gregory Davies, Christine M. Armour

Erschienen in: Journal of Genetic Counseling | Ausgabe 3/2016

Einloggen, um Zugang zu erhalten

Abstract

The purpose of this study was to explore the definition of fetal viability and the availability, indications, and decision making processes for post-viability termination of pregnancy for fetal abnormalities and health conditions in Canada. An online survey of members of the Canadian Association of Genetic Counsellors, the Canadian College of Medical Geneticists, and the Canadian Society for Maternal-Fetal Medicine who provide direct counselling to, or management of, prenatal patients in Canada (total sample size 815). Results of this study showed that the majority of respondents indicated that their centre will offer post-viability termination of pregnancy (98/123; 80 %). Sixty-seven percent (68/101) of respondents reported the definition of fetal viability to be 24 weeks’ gestation. Most respondents reported that a collaborative decision making process was used to determine if post-viability termination of pregnancy would be offered (136/170; 80 %). For conditions presumed to be lethal/likely lethal, the majority of respondents would “sometimes” or “always” offer post-viability termination of pregnancy, whereas for conditions presumed to have a mild effect, the majority of respondents would “rarely” or “never” offer post-viability termination of pregnancy. Ninety percent (77/86) of respondents reported that perinatal hospice is offered as an alternative to termination of pregnancy. In conclusion, this study suggests that although post-viability termination is available in many provinces in Canada, variation in the definition of fetal viability and indications appear to exist. While these variations may lead to unequal access to post-viability termination of pregnancy across Canada, they might also represent the complexity of the decision making process and the importance of examining individual factors to ensure that the most appropriate decision is made in each case.
Literatur
Zurück zum Zitat Abortion Rights Coalition of Canada. (2005). Position paper #22. late term abortions (after 20 weeks’). Abortion Rights Coalition of Canada. (2005). Position paper #22. late term abortions (after 20 weeks’).
Zurück zum Zitat Black, A., Francoceur, D., Rowe, T., Collins, J., & Miller, D. (2004). Canadian contraception consensus. Journal of Obstetrics and Gynaecology Canada, 26, 143–56.CrossRefPubMed Black, A., Francoceur, D., Rowe, T., Collins, J., & Miller, D. (2004). Canadian contraception consensus. Journal of Obstetrics and Gynaecology Canada, 26, 143–56.CrossRefPubMed
Zurück zum Zitat Canadian Institute for Health Information. (2012). Induced abortions reported in Canada in 2012. Ottawa: Canadian Institute for Health Information. Canadian Institute for Health Information. (2012). Induced abortions reported in Canada in 2012. Ottawa: Canadian Institute for Health Information.
Zurück zum Zitat Canadian Medical Association. (1988). PD88-06: Induced Abortion [CMA Policy]. Canadian Medical Association. (1988). PD88-06: Induced Abortion [CMA Policy].
Zurück zum Zitat Davis, V. J. (2006). Induced abortion guidelines. Journal of Obstetrics and Gynaecology Canada, 28(11), 1014–1027.CrossRef Davis, V. J. (2006). Induced abortion guidelines. Journal of Obstetrics and Gynaecology Canada, 28(11), 1014–1027.CrossRef
Zurück zum Zitat Government of Canada. (2011). Canada health act annual reports 2010–2011. Government of Canada. (2011). Canada health act annual reports 2010–2011.
Zurück zum Zitat Hoeldtke, N. J., & Calbourn, B. C. (2001). Perinatal hospice. American Journal of Obstetrics and Gynecology, 185(3), 525.CrossRefPubMed Hoeldtke, N. J., & Calbourn, B. C. (2001). Perinatal hospice. American Journal of Obstetrics and Gynecology, 185(3), 525.CrossRefPubMed
Zurück zum Zitat Hull, D., Davies, G., & Armour, C. M. (2012). Survey of prenatal counselling practices regarding aneuploidy risk modification, invasive diagnostic procedure risks, and procedure eligibility criteria in Canadian centres. Journal of Obstetrics and Gynaecology Canada, 34(7), 626–36.CrossRefPubMed Hull, D., Davies, G., & Armour, C. M. (2012). Survey of prenatal counselling practices regarding aneuploidy risk modification, invasive diagnostic procedure risks, and procedure eligibility criteria in Canadian centres. Journal of Obstetrics and Gynaecology Canada, 34(7), 626–36.CrossRefPubMed
Zurück zum Zitat Sabourin, J. N., & Burnett, M. (2012). A review of therapeutic abortions and related areas of concern in Canada. Journal of Obstetrics and Gynaecology Canada, 34(6), 532–42.CrossRefPubMed Sabourin, J. N., & Burnett, M. (2012). A review of therapeutic abortions and related areas of concern in Canada. Journal of Obstetrics and Gynaecology Canada, 34(6), 532–42.CrossRefPubMed
Zurück zum Zitat Jefferies, A. L., & Kirpalani, H. M. (2012). Canadian paediatric society fetus and newborn committee. Counselling and management for anticipated extremely preterm birth. Paediatrics & Child Health, 17(8), 443–6. Jefferies, A. L., & Kirpalani, H. M. (2012). Canadian paediatric society fetus and newborn committee. Counselling and management for anticipated extremely preterm birth. Paediatrics & Child Health, 17(8), 443–6.
Zurück zum Zitat Langlois, S., Brock, J. A., Committee, G., Wilson, R. D., Audibert, F., Brock, J. A., et al. (2013). Current status in non-invasive prenatal detection of down syndrome, trisomy 18, and trisomy 13 using cell-free DNA in maternal plasma. Journal of Obstetrics and Gynaecology Canada, 35(2), 177–83.CrossRefPubMed Langlois, S., Brock, J. A., Committee, G., Wilson, R. D., Audibert, F., Brock, J. A., et al. (2013). Current status in non-invasive prenatal detection of down syndrome, trisomy 18, and trisomy 13 using cell-free DNA in maternal plasma. Journal of Obstetrics and Gynaecology Canada, 35(2), 177–83.CrossRefPubMed
Zurück zum Zitat Sethna, C., & Doull, M. (2007). Far from home? A pilot study tracking women’s journeys to a Canadian abortion clinic. Journal of Obstetrics and Gynaecology Canada, 27(8), 640–647.CrossRef Sethna, C., & Doull, M. (2007). Far from home? A pilot study tracking women’s journeys to a Canadian abortion clinic. Journal of Obstetrics and Gynaecology Canada, 27(8), 640–647.CrossRef
Zurück zum Zitat Synnes AR, Buchanan L, Albersheim S. (2008). Management of the newborn delivered at the threshold of viability. BC Medical Journal 50(9). Synnes AR, Buchanan L, Albersheim S. (2008). Management of the newborn delivered at the threshold of viability. BC Medical Journal 50(9).
Metadaten
Titel
Survey of the Definition of Fetal Viability and the Availability, Indications, and Decision Making Processes for Post-Viability Termination of Pregnancy for Fetal Abnormalities and Health Conditions in Canada
verfasst von
Danna Hull
Gregory Davies
Christine M. Armour
Publikationsdatum
05.11.2015
Verlag
Springer US
Erschienen in
Journal of Genetic Counseling / Ausgabe 3/2016
Print ISSN: 1059-7700
Elektronische ISSN: 1573-3599
DOI
https://doi.org/10.1007/s10897-015-9907-8

Weitere Artikel der Ausgabe 3/2016

Journal of Genetic Counseling 3/2016 Zur Ausgabe

Hirsutismus bei PCOS: Laser- und Lichttherapien helfen

26.04.2024 Hirsutismus Nachrichten

Laser- und Lichtbehandlungen können bei Frauen mit polyzystischem Ovarialsyndrom (PCOS) den übermäßigen Haarwuchs verringern und das Wohlbefinden verbessern – bei alleiniger Anwendung oder in Kombination mit Medikamenten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

22.04.2024 DGIM 2024 Kongressbericht

Durch die Häufung nach der COVID-19-Pandemie sind Infektionen mit dem Respiratorischen Synzytial-Virus (RSV) in den Fokus gerückt. Fachgesellschaften empfehlen eine Impfung inzwischen nicht nur für Säuglinge und Kleinkinder.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.